| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/07/2005 | US20050075334 Novel compounds |
| 04/07/2005 | US20050075330 Dipeptidyl peptidase inhibitors |
| 04/07/2005 | US20050075310 Gangliosides with a modified acyl function |
| 04/07/2005 | US20050075305 Therapeutic compositions and methods of treating glycolipid storage related disorders |
| 04/07/2005 | US20050075294 E.g., 2-(4-Methoxybenzyl)phenyl beta -D-glucopyranoside; inhibitors of human SGLT2 (Na+/glucose cotransporter 2); prevents reabsorption of excess glucose at the kidney, promotes excreting excess glucose though the urine, and normalizes blood glucose level; hypoglycemic and antidiabetic agent; obesity |
| 04/07/2005 | US20050075269 Substituted benzofuran-2-carboxamides derivatives |
| 04/07/2005 | US20050074841 DNAs encoding mammalian histamine receptor of the H4 subtype |
| 04/07/2005 | US20050074805 Specific markers for diabetes |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074756 FALP proteins |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074470 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 04/07/2005 | US20050074449 Microparticle formulations; controlling immune response; including surfactants, excipients and antigens |
| 04/07/2005 | US20050074436 Systems and methods for treating patients with processed lipoaspirate cells |
| 04/07/2005 | US20050074434 Remedies for metabolic bone diseases |
| 04/07/2005 | DE19845402B4 Mit Heterocyclen substituierte Propanolaminderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung -Containing heterocycles substituted with Propanolaminderivate, process for their production, medicaments containing these compounds and their use |
| 04/07/2005 | CA2554982A1 Method of inhibiting remnant lipoprotein production |
| 04/07/2005 | CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | CA2539976A1 Therapeutic beta aminoacids |
| 04/07/2005 | CA2539961A1 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro[3a,3,2] [2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 04/07/2005 | CA2539403A1 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| 04/07/2005 | CA2538694A1 Heterocyclic- or aryloxy, -thio or -amino substituted indoles-2-carboxylic acids or esters as pai-1 |
| 04/07/2005 | CA2538263A1 Substituted sulfonamide-indole-2-carboxylic acid derivatives as pai-1 inhibitors |
| 04/07/2005 | CA2506282A1 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 04/06/2005 | EP1520582A2 Use of dipeptidylpetidase inhibitors to regulate glucose metabolism |
| 04/06/2005 | EP1520581A1 Composition based on a thiazolidinedione and metformin and its use |
| 04/06/2005 | EP1520580A1 Creatine composition and use |
| 04/06/2005 | EP1520486A1 Composition for suppressing ghrelin and method for same |
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1520021A2 Antisense modulation of lrh1 expression |
| 04/06/2005 | EP1520003A1 Process for recovery of plant sterols from by-product of vegetable oil refining |
| 04/06/2005 | EP1519961A1 Low molecular weight oversulfated polysaccharide |
| 04/06/2005 | EP1519925A1 Oxazole derivatives and their use as insulin sensitizers |
| 04/06/2005 | EP1519920A1 Novel tetrahydropyridine derivatives as renin inhibitors |
| 04/06/2005 | EP1519919A1 Indolin phenylsulfonamide derivatives |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519908A2 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 04/06/2005 | EP1519754A1 Use of cetp inhibitors and optionally hmg coa reductase inhibitors and/or antihypertensive agents |
| 04/06/2005 | EP1519752A1 Use of cetp inhibitors and antihypertensive agents as well as optionally hmg coa reductase inhibitors |
| 04/06/2005 | EP1519751A2 Compositions comprising panthetine for the treatment of dyslipidemia |
| 04/06/2005 | EP1519743A1 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 04/06/2005 | EP1519732A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 04/06/2005 | EP1519730A1 Novel use of imidazotriazinones |
| 04/06/2005 | EP1519723A1 Novel glucagon antagonists/inverse agonists |
| 04/06/2005 | EP1519720A2 Novel formate salt of o-desmethyl-venlafaxine |
| 04/06/2005 | EP1406898B1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 04/06/2005 | EP1392656A4 Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
| 04/06/2005 | EP1353909B1 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
| 04/06/2005 | EP1311258B1 Compositions containing hypotriglyceridemically active stilbenoids |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1248652B1 Stable aqueous deoxyfructosazine solution |
| 04/06/2005 | EP1231918B1 Novel composition based on a thiazolidinedione and metformin and use |
| 04/06/2005 | EP1214084B1 An anti-oxidant preparation based on plant extracts for the treatment of circulation and adiposity problems |
| 04/06/2005 | EP1028733B1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | EP0912521B1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf) |
| 04/06/2005 | EP0748219B1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/06/2005 | CN1604968A Methods to treat diabetes and related conditions based on polymorphisms in the TCF-1 gene |
| 04/06/2005 | CN1604965A 生长激素融合蛋白 Growth hormone fusion protein |
| 04/06/2005 | CN1604904A Phosphonic acid compounds as inhibitors of serine proteases |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1604900A 6-aminomorphinane derivatives, method for production and use thereof |
| 04/06/2005 | CN1604898A 3-heteroaryl-3, 5-dihydro-4-oxo-4h-pyridazino[4, 5-b]indole-1-carboxamide derivatives, their preparation, their intermediates and pharmaceutical compositions containing the compounds |
| 04/06/2005 | CN1604892A Prodrugs to d-prolines |
| 04/06/2005 | CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives |
| 04/06/2005 | CN1603342A Caspase-8 interacting proteins |
| 04/06/2005 | CN1602960A Mixture for preventing and treating metabolic syndrome like cerebrovascular and cardiovascular disease |
| 04/06/2005 | CN1602959A Nutrient product for enhancing immunity, preventing cancer and prolonging life of cancer patient and its preparing method |
| 04/06/2005 | CN1602948A Gingko leaf dispersible tablet and its preparing process |
| 04/06/2005 | CN1602926A Kudzuvine root containing capsule capable of regulating blood pressure and blood fat, preventing and treating cardiovascular and cerebrovascular diseases |
| 04/06/2005 | CN1602921A Medicine for treating diabetes and its preparing process |
| 04/06/2005 | CN1602894A Health protecting product composition with liver protecting and blood fat regulating function and its preparation |
| 04/06/2005 | CN1602882A Orally disintegrating tablet of gypenosides and its preparation process |
| 04/06/2005 | CN1602880A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602879A Method for inhibitting bone resorption |
| 04/06/2005 | CN1602873A Sustained release preparation of glipizide/metformin hydrochloride and its preparation method |
| 04/06/2005 | CN1602863A Dripping pills of furazabol and its preparation method |
| 04/06/2005 | CN1602855A Application of forsythin in the process for preparing adiposis treating oral medicine and healthy food |
| 04/06/2005 | CN1602850A Nú¿2ú®-L-alanyl-L-glutamine injection and its preparation method |
| 04/06/2005 | CN1602845A Fenfluramine hydrochloride drop pills and its preparation method |
| 04/06/2005 | CN1195858C OB fusion protein compositions and methods |
| 04/06/2005 | CN1195843C Solid culture method of antrodia camphorate, its cultured solid substance, and its product and application |
| 04/06/2005 | CN1195778C Cell adhension inhibitors |
| 04/06/2005 | CN1195776C Treatmet of obesity |
| 04/06/2005 | CN1195773C Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 04/06/2005 | CN1195772C Nb heterocyclic 8-modified adenosine derivs. |
| 04/06/2005 | CN1195762C Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and compositions containing same |
| 04/06/2005 | CN1195755C Pyrrolo [2, 3-d] pyrimidine compounds |
| 04/06/2005 | CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/06/2005 | CN1195747C 8, 8a-dihydro-indeno [1, 2-d] thiazole derivatives, substituted in position 8a, a method for their production and their use as medicaments, e.g. anorectic agents |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195728C Novel compounds to treat diabetes and associated conditions |
| 04/06/2005 | CN1195546C Application of monoclone antibody combined with CD154 for inhibiting rejection of insulin generating transplanted tissue |
| 04/06/2005 | CN1195543C Method for administering monomeric insulin analogs |
| 04/06/2005 | CN1195534C Physiologically active compositions of basidiomycotina and araliaceae extracts |
| 04/06/2005 | CN1195522C Benzodiazepine derivatives |
| 04/05/2005 | US6875867 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 04/05/2005 | US6875843 Reducing the rate of islet cell infiltration by lymphocytes in a diabetes-susceptible mammal by administering a gonadotropin-releasing hormone antagonist. |